Comparing Two Radiotherapy Regimens for Lung Cancer
Author Information
Author(s): N.M. Bleehen, D.J. Girling, P.M. Fayers, V.R. Aber, R.J. Stephens
Primary Institution: Medical Research Council
Hypothesis
Does a shorter course of palliative radiotherapy provide equally effective symptom relief for patients with inoperable non-small-cell lung cancer compared to a conventional regimen?
Conclusion
Both radiotherapy regimens provided similar levels of symptom palliation for patients with inoperable non-small-cell lung cancer.
Supporting Evidence
- 93% of patients had cough, 47% had haemoptysis, and 57% had chest pain at admission.
- Palliation was achieved in 65% of patients for cough in the F2 group and 56% in the FM group.
- The median survival time was 179 days for the F2 group and 177 days for the FM group.
- Performance status improved in approximately half of the patients with poor status on admission.
- Quality of life deteriorated slightly during treatment but improved steadily in the following weeks.
Takeaway
Doctors tested two ways to give radiation to help people with lung cancer feel better, and both ways worked about the same.
Methodology
Patients were randomly assigned to receive either two fractions of 8.5 Gy or a conventional regimen of 30 Gy in ten fractions.
Limitations
The study did not include a no-radiotherapy control group, making it difficult to determine the extent of palliation due to radiotherapy alone.
Participant Demographics
71% of patients were aged 65 years or over, 80% had squamous cell tumors, and 78% were male.
Statistical Information
P-Value
0.8
Statistical Significance
p=0.8
Want to read the original?
Access the complete publication on the publisher's website